Literature DB >> 9153684

Assessment of the dysexecutive syndrome in schizophrenia.

J J Evans1, S E Chua, P J McKenna, B A Wilson.   

Abstract

BACKGROUND: Cognitive neuropsychological theories hypothesize a role for frontal lobe executive deficits in the aetiology of schizophrenic symptoms. The study examined the performance of a schizophrenic group on the Behavioural Assessment of the Dysexecutive Syndrome (BADS; Wilson et al. 1996), a test battery which assesses the 'everyday' difficulties associated with the dysexecutive syndrome. Performance of the schizophrenics was contrasted with that of brain injured and healthy volunteer groups.
METHODS: Matched groups of 31 schizophrenic patients, 35 patients with brain injuries and 26 healthy volunteers were administered the BADS. Patients were also given tests of general intelligence and memory. Patients and their relatives/carers also completed a questionnaire rating day-to-day failures of executive functioning.
RESULTS: Schizophrenic and brain-injured patients showed impairment on the BADS, compared to healthy controls. There were no significant differences between the two patient groups. Significant impairment was found in a subgroup of 16 schizophrenics who showed otherwise intact general intellectual functioning, suggesting the existence of a specific executive deficit. Among the schizophrenic patient group there was evidence of a dissociation between executive and memory impairments. A significant correlation existed between performance on the BADS and relatives ratings of executive problems for the brain injured group, but not for the schizophrenic group.
CONCLUSIONS: The BADS is a useful tool for identifying executive deficits in people with a diagnosis of schizophrenia, especially those who are otherwise generally intellectually intact. This is particularly important in the context of rehabilitation and community transition programmes.

Entities:  

Mesh:

Year:  1997        PMID: 9153684     DOI: 10.1017/s0033291797004790

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  22 in total

1.  Asperger syndrome and nonverbal learning difficulties in adult males: self- and parent-reported autism, attention and executive problems.

Authors:  Bibbi Hagberg; Eva Billstedt; Agneta Nydén; Christopher Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-16       Impact factor: 4.785

2.  The role of brain oscillations as functional correlates of cognitive systems: a study of frontal inhibitory control in alcoholism.

Authors:  Chella Kamarajan; Bernice Porjesz; Kevin A Jones; Keewhan Choi; David B Chorlian; Ajayan Padmanabhapillai; Madhavi Rangaswamy; Arthur T Stimus; Henri Begleiter
Journal:  Int J Psychophysiol       Date:  2004-01       Impact factor: 2.997

3.  Investigating multitasking in high-functioning adolescents with autism spectrum disorders using the Virtual Errands Task.

Authors:  Gnanathusharan Rajendran; Anna S Law; Robert H Logie; Marian van der Meulen; Diane Fraser; Martin Corley
Journal:  J Autism Dev Disord       Date:  2011-11

4.  How do individuals with Asperger syndrome respond to nonliteral language and inappropriate requests in computer-mediated communication?

Authors:  Gnanathusharan Rajendran; Peter Mitchell; Hugh Rickards
Journal:  J Autism Dev Disord       Date:  2005-08

5.  Homocysteine and cognition in first-episode psychosis patients.

Authors:  Rosa Ayesa-Arriola; Rocío Pérez-Iglesias; José Manuel Rodríguez-Sánchez; Ignacio Mata; Elsa Gómez-Ruiz; Maite García-Unzueta; Obdulia Martínez-García; Rafael Tabares-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-02       Impact factor: 5.270

6.  Following Instructions in Patients With Schizophrenia: The Benefits of Actions at Encoding and Recall.

Authors:  Simon S Y Lui; Tian-Xiao Yang; Chris L Y Ng; Peony T Y Wong; Jessica O Y Wong; Ulrich Ettinger; Eric F C Cheung; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

Review 7.  First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

Authors:  Thomas W Weickert; Terry E Goldberg
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

8.  Group and case study of the dysexecutive syndrome in alcoholism without amnesia.

Authors:  H Ihara; G E Berrios; M London
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

9.  Enhancement of executive functioning skills: an additional tier in the treatment of schizophrenia.

Authors:  Deana B Davalos; Mack Green; Daniel Rial
Journal:  Community Ment Health J       Date:  2002-10

Review 10.  Understanding executive control in autism spectrum disorders in the lab and in the real world.

Authors:  Lauren Kenworthy; Benjamin E Yerys; Laura Gutermuth Anthony; Gregory L Wallace
Journal:  Neuropsychol Rev       Date:  2008-10-28       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.